PRESCRIBING · PART D · 2024
Total Rx claims
25
Beneficiaries
—
Total drug cost
$7K
Distinct drugs
2
Brand share
48.0%
Top prescribed drugs
Estradiol13 claims
Mirabegron12 claims
QUALITY · MIPS · 2024
Final MIPS score
99.6
Quality
86.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.04%
APM Entity
REFERRAL NETWORK
Where My-Le To's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · Sacramento, CA | 30 | 93 |
| DIGNITY COMMUNITY CARE | 25 | 73 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE